Consensus elements for observational research on COVID-19-related long-term outcomes

Andrew J Admon, Pandora L Wander, Theodore J Iwashyna, George N Ioannou, Edward J Boyko, Denise M Hynes, C Barrett Bowling, Amy S B Bohnert, Ann M O'Hare, Valerie A Smith, John Pura, Paul L Hebert, Edwin S Wong, Meike Niederhausen, Matthew L Maciejewski, Andrew J Admon, Pandora L Wander, Theodore J Iwashyna, George N Ioannou, Edward J Boyko, Denise M Hynes, C Barrett Bowling, Amy S B Bohnert, Ann M O'Hare, Valerie A Smith, John Pura, Paul L Hebert, Edwin S Wong, Meike Niederhausen, Matthew L Maciejewski

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its long-term outcomes may be jointly caused by a wide range of clinical, social, and economic characteristics. Studies aiming to identify mechanisms for SARS-CoV-2 morbidity and mortality must measure and account for these characteristics to arrive at unbiased, accurate conclusions. We sought to inform the design, measurement, and analysis of longitudinal studies of long-term outcomes among people infected with SARS-CoV-2. We fielded a survey to an interprofessional group of clinicians and scientists to identify factors associated with SARS-CoV-2 infection and subsequent outcomes. Using an iterative process, we refined the resulting list of factors into a consensus causal diagram relating infection and 12-month mortality. Finally, we operationalized concepts from the causal diagram into minimally sufficient adjustment sets using common medical record data elements. Total 31 investigators identified 49 potential risk factors for and 72 potential consequences of SARS-CoV-2 infection. Risk factors for infection with SARS-CoV-2 were grouped into five domains: demographics, physical health, mental health, personal social, and economic factors, and external social and economic factors. Consequences of coronavirus disease 2019 (COVID-19) were grouped into clinical consequences, social consequences, and economic consequences. Risk factors for SARS-CoV-2 infection were developed into a consensus directed acyclic graph for mortality that included two minimally sufficient adjustment sets. We present a collectively developed and iteratively refined list of data elements for observational research in SARS-CoV-2 infection and disease. By accounting for these elements, studies aimed at identifying causal pathways for long-term outcomes of SARS-CoV-2 infection can be made more informative.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1.
Figure 1.
Directed acyclic graph (DAG) for a hypothetical study evaluating the impact of SARS-CoV-2 infection on 12-month mortality. SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
Figure 2.
Figure 2.
Consensus DAG describing the relationship between SARS-CoV-2 test positivity and 12-month mortality. DAG = directed acyclic graph; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.

References

    1. Centers for Disease Control and Prevention. COVID Data Tracker. 2022. Available at: [access date February 28, 2022].
    1. Iwashyna TJ, Kamphuis LA, Gundel SJ, et al. . NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Network Continuing cardiopulmonary symptoms, disability, and financial toxicity 1 month after hospitalization for Third-Wave COVID-19: early results from a US Nationwide Cohort. J Hosp Med. 2021. Aug 18. doi: 10.12788/jhm.3660. [Epub ahead of print].
    1. Chopra V, Flanders SA, O’Malley M, et al. . Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174:576–8.
    1. Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.
    1. Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in Adults at 6 Months After COVID-19 infection. JAMA Netw Open. 2021;4:e210830.
    1. Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021;22:e102–e107.
    1. Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ 2021;374:n1648.
    1. Tennant PWG, Murray EJ, Arnold KF, et al. . Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. Int J Epidemiol. 2021;50:620–32.
    1. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48.
    1. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615–25.
    1. Lederer DJ, Bell SC, Branson RD, et al. . Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc. 2019;16:22–8.
    1. Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:702669–710.
    1. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003;14:300–6.
    1. Matthay EC, Glymour MM. A graphical catalog of threats to validity: linking social science with epidemiology. Epidemiology. 2020;31:376–84.
    1. Lipsky AM, Greenland S. Causal directed acyclic graphs. JAMA. 2022;327:1083–4.
    1. Knuppel S, Stang A. DAG program: identifying minimal sufficient adjustment sets. Epidemiology. 2010;21:159.
    1. Textor J, van der Zander B, Gilthorpe MS, et al. . Robust causal inference using directed acyclic graphs: the R package “dagitty”. Int J Epidemiol. 2016;45:1887–94.
    1. Admon AJ, Bohnert ASB, Cooke CR, et al. . Beyond confounding: identifying selection bias in observational pulmonary and critical care research. Ann Am Thorac Soc. 2022;19:1084–9.
    1. Griffith GJ, Morris TT, Tudball MJ, et al. . Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11:5749.
    1. Lash TL, Fox MP, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. Dordrecht, Netherlands: Springer, 2009.
    1. Sayon-Orea C, Moreno-Iribas C, Delfrade J, et al. . Inverse-probability weighting and multiple imputation for evaluating selection bias in the estimation of childhood obesity prevalence using data from electronic health records. BMC Med Inform Decis Mak. 2020;20:9.
    1. Nohr EA, Liew Z. How to investigate and adjust for selection bias in cohort studies. Acta Obstet Gynecol Scand. 2018;97:407–16.
    1. Boudreau JH, Miller DR, Qian S, et al. . Access to lung cancer screening in the veterans health administration: does geographic distribution match need in the population? Chest. 2021;160:358–67.
    1. Wang V, Zepel L, Diamantidis CJ, et al. . Annual wellness visits and care management before and after dialysis initiation. BMC Nephrol. 2021;22:164.
    1. Gatwood JD, Chisholm-Burns M, Davis R, et al. . Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes. BMC Health Serv Res. 2018;18:855.
    1. Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9:1275–87.
    1. Wright B, O’Shea AMJ, Glasgow JM, et al. . Patient, hospital, and local health system characteristics associated with the use of observation stays in veterans health administration hospitals, 2005 to 2012. Medicine (Baltim). 2016;95:e4802.
    1. Wong MS, Steers WN, Hoggatt KJ, et al. . Relationship of neighborhood social determinants of health on racial/ethnic mortality disparities in US veterans-Mediation and moderating effects. Health Serv Res. 2020;55(Suppl 2):851–62.
    1. Yoon J, Zulman D, Scott JY, et al. . Costs associated with multimorbidity among VA patients. Med Care. 2014;52(Suppl 3):S31–36.
    1. Kim DH, Glynn RJ, Avorn J, et al. . Validation of a claims-based frailty index against physical performance and adverse health outcomes in the Health and Retirement Study. J Gerontol A Biol Sci Med Sci. 2019;74:1271–6.
    1. Hall DE, Arya S, Schmid KK, et al. . Development and initial validation of the risk analysis index for measuring frailty in surgical populations. JAMA Surg. 2017;152:175–82.
    1. Palacio A, Tamariz L. Social determinants of health mediate COVID-19 disparities in South Florida. J Gen Intern Med. 2021;36:472–7.
    1. Milicevic AS, Mitsantisuk K, Tjader A, et al. . Modeling patient no-show history and predicting future appointment behavior at the veterans administration’s outpatient mental health clinics: NIRMO-2. Mil Med. 2020;185:e988–94.
    1. Schmajuk G, Tonner C, Yazdany J. Factors associated with access to rheumatologists for Medicare patients. Semin Arthritis Rheum. 2016;45:511–8.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj